Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients

By Fisher R.A.   Pan S.-H.   Rossi S.J.   Schroeder T.J.   Irish W.D.   Canafax D.M.   Lopez R.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 394-395

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients

By Gaston R.   Alloway R.R.   Gaber A.O.   Rossi S.J.   Schroeder T.J.   Irish W.D.   Canafax D.M.   First M.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 326-327

Elsevier

Access to resources Recommend Favorite

Conversion of stable renal transplant recipients from sandimmune to sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method

By First M.R.   Weiskittel P.   Burton M.   Shah M.   Dreyer D.   Fleck P.   Bey C.   Peddi R.   Canafax D.   Schroeder T.J.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1701-1705

Elsevier

Access to resources Recommend Favorite

Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method

By First M.R.   Weiskittel P.   Shah M.   Peddi V.R.   Canafax D.   Schroeder T.J.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 3955-3957

Elsevier

Access to resources Recommend Favorite

Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up

By Citterio F.   Scata M.C.   Romagnoli J.   Pozzetto U.   Nanni G.   Castagneto M.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1685-1686

Elsevier

Access to resources Recommend Favorite